- What we (don't) know today about proton pump inhibitors2008 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Skin toxicity of BRAF and MEK inhibitors2021 | First Faculty of Medicine
- DPP-4 inhibitors and autoimmunity2014 | First Faculty of Medicine, Third Faculty of Medicine
- Inhibitors of DPP-4 and cardiovascular effects2016 | Faculty of Medicine in Pilsen
- Second-generation integrase inhibitors2016 | First Faculty of Medicine
- Proton pump inhibitors in clinical practice use2010 | Faculty of Medicine in Hradec Králové
- Use of aromatase inhibitors to stimulate the ovaries2006 | Publication without faculty affiliation
- Proton pump inhibitors by children2022 | First Faculty of Medicine
- Plant Kunitz Protease Inhibitors: Structural and Functional Diversity2016 | Faculty of Science
- Current and Novel Inhibitors of HIV Protease2009 | Faculty of Science, Third Faculty of Medicine
- Inhibitors of platelet glycoprotein receptors type IIb/IIIa2003 | Second Faculty of Medicine
- Kidney cancer. What is the next step after failure of treatment with angiogenesis inhibitors?2010 | Second Faculty of Medicine
- Therapeutic proton pump inhibitor test2016 | Second Faculty of Medicine
- Angiotensin-converting enzyme inhibitor-induced angioedema2019 | First Faculty of Medicine, Second Faculty of Medicine
- Effect of target therapy with BRAF and MEK inhibitors on the immune system in metastatic melanoma2023 | First Faculty of Medicine
- Histondeacetylases and their inhibitors +12009 | Faculty of Medicine in Hradec Králové
- Study of acetylcholinesterase inhibitorsPublication without faculty affiliation
- When not even four ALK inhibitors are enough2020 | Faculty of Medicine in Pilsen
- Gliflozines: inhibitors of SGLT 22013 | Second Faculty of Medicine
- ROCK inhibitors as emerging therapeutic candidates for sarcomas2010 | Faculty of Medicine in Hradec Králové, Faculty of Science
- Ideal patient for IL-17 inhibitors treatment2022 | First Faculty of Medicine
- Comparison of clinical efficacy of DPP-4 inhibitors sitagliptin and vildagliptin2009 | Second Faculty of Medicine
- New potential checkpoint inhibitors in cancer therapy2022 | Faculty of Medicine in Hradec Králové
- Proteasome inhibitors in the treatment of multiple myeloma2021 | Faculty of Medicine in Hradec Králové
- ACE inhibitors2008 | First Faculty of Medicine
- PARP inhibitors in the therapy of ovarian cancer2019 | Faculty of Medicine in Pilsen
- Phosphodiesterase inhibitors - a new promise in the tratment of COPD?2010 | Second Faculty of Medicine
- Inhibitors of Janus kinases in the therapy of rheumatoid arthritis2019 | First Faculty of Medicine
- Selectivity of DPP-4 inhibitors and heart failure2016 | First Faculty of Medicine